- Home
- MRVI vs MLP Comparison
MRVI vs MLP Comparison
Compare MRVI & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- MLP
- Stock Information
- Founded
- MRVI 2014
- MLP 1909
- Country
- MRVI United States
- MLP United States
- Employees
- MRVI N/A
- MLP N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- MLP Real Estate
- Sector
- MRVI Health Care
- MLP Finance
- Exchange
- MRVI Nasdaq
- MLP Nasdaq
- Market Cap
- MRVI 262.9M
- MLP 295.0M
- IPO Year
- MRVI 2020
- MLP 1972
- Fundamental
- Price
- MRVI $2.12
- MLP $15.24
- Analyst Decision
- MRVI Hold
- MLP
- Analyst Count
- MRVI 9
- MLP 0
- Target Price
- MRVI $6.54
- MLP N/A
- AVG Volume (30 Days)
- MRVI 1.7M
- MLP 20.9K
- Earning Date
- MRVI 05-12-2025
- MLP 05-16-2025
- Dividend Yield
- MRVI N/A
- MLP N/A
- EPS Growth
- MRVI N/A
- MLP N/A
- EPS
- MRVI N/A
- MLP N/A
- Revenue
- MRVI $259,185,000.00
- MLP $11,565,000.00
- Revenue This Year
- MRVI N/A
- MLP N/A
- Revenue Next Year
- MRVI $11.14
- MLP N/A
- P/E Ratio
- MRVI N/A
- MLP N/A
- Revenue Growth
- MRVI N/A
- MLP 24.50
- 52 Week Low
- MRVI $1.67
- MLP $14.05
- 52 Week High
- MRVI $11.56
- MLP $26.46
- Technical
- Relative Strength Index (RSI)
- MRVI 50.73
- MLP 45.04
- Support Level
- MRVI $1.96
- MLP $14.52
- Resistance Level
- MRVI $2.16
- MLP $15.27
- Average True Range (ATR)
- MRVI 0.12
- MLP 0.65
- MACD
- MRVI 0.04
- MLP 0.07
- Stochastic Oscillator
- MRVI 65.31
- MLP 34.45
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.